Akari Therapeutics reported cash from operations of -$0.00B and free cash flow of -$0.00B for the quarter ended Jun 2026, up 4.5% year over year. This cash flow statement covers 42 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2012 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Dec2016 | Jun2017 | Dec2017 | Jun2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||||
| Net Income | -0.00B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | ||||||||||||||||||||||||
| Share-based Compensation | 0.00B | 0.00B | 0.12B | 0.14B | 0.38B | 0.00B | 0.00B | 0.98B | 0.00B | 0.00B | 1.84B | 0.35B | 0.51B | 0.00B | 14.39B | 19.17B | 7.42B | 0.00B | 0.15B | 0.24B | ||||||||||||||||||||||
| Deferred Taxes | 0.00B | -0.00B | ||||||||||||||||||||||||||||||||||||||||
| Gains from Investment Securities | ||||||||||||||||||||||||||||||||||||||||||
| Asset Writedowns and Impairment | 0.01B | 0.00B | ||||||||||||||||||||||||||||||||||||||||
| Non-cash Items | -0.00B | 0.00B | ||||||||||||||||||||||||||||||||||||||||
| Cash from Operations | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 986.00 | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||||
| Change in Account Payables | ||||||||||||||||||||||||||||||||||||||||||
| Change in Accured Expenses | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||
| Other Working Capital Changes | ||||||||||||||||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | ||||||||||||||||||||||||||||||||||||||||||
| Cash from Investing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Other financing activities | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuances | 0.00B | |||||||||||||||||||||||||||||||||||||||||
| Short-Term Debt issuances | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.00B | 0.04B | 0.06B | 0.02B | 0.01B | 0.03B | 0.00B | |||||||||||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | 0.01B | ||||||||||||||||||||||||||||
| Exchange Rate Effect | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | |||||||||||||||||||||||||||||||||
| Change in Cash | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | ||||||||||||||||||||||||||
| Free Cash Flow | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||||||||||||||||
| Net Cash Flow | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B |